Scout | Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

This opportunity is no longer accepting applications.

grant

Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

This grant opportunity provides funding for clinical research projects aimed at exploring and developing an understanding of the neurobiological mechanisms behind substance use disorders (SUD). It supports projects that are in the exploratory or developmental stages and require larger budgets than typically allowed for under similar grant mechanisms. The focus is on fundamental brain function …

Source

Agency: National Institutes of Health

Sub-agency: National Institute on Drug Abuse

Program: SBIR

Dates

Opportunity Released: April 10, 2023

Open for Submission: April 10, 2023

Submission Deadline: May 7, 2026

Application Window Closes: May 7, 2026

Keywords

Neurobiology

Substance Use Disorder

Clinical Research

Phased Innovation Award

Developmental Projects

Brain Function

Drug Abuse

Exploratory Research

R61/R33 Mechanism

Neuroscience.

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers